FDA Inspection 1224859 — Bushu Pharmaceuticals Ltd
The FDA completed an inspection of Bushu Pharmaceuticals Ltd on November 10, 2023 in Kodama-Gun. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 10, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Kodama-Gun (Japan)